Trastuzumab beyond progression in metastatic breast cancer
dc.authorid | Turna, Hande/0000-0003-0558-9371 | |
dc.authorid | MUSTAFA, ÖZGÜROĞLU/0000-0002-8417-8628 | |
dc.authorwosid | Basaran, Gul Atalay/AAT-7780-2020 | |
dc.authorwosid | Turna, Hande/AAA-2972-2020 | |
dc.authorwosid | Uygun, Kazim/AAG-7880-2022 | |
dc.authorwosid | Uygun, Kazim/AFL-7917-2022 | |
dc.authorwosid | MUSTAFA, ÖZGÜROĞLU/A-8234-2016 | |
dc.contributor.author | Yanmaz, Mustafa T. | |
dc.contributor.author | Ozguroglu, Mustafa | |
dc.contributor.author | Ozturk, Betul | |
dc.contributor.author | Uygun, Kazim | |
dc.contributor.author | Basaran, Gul | |
dc.contributor.author | Turna, Hande | |
dc.contributor.author | Yildiz, Ozcan | |
dc.date.accessioned | 2024-06-12T11:23:55Z | |
dc.date.available | 2024-06-12T11:23:55Z | |
dc.date.issued | 2006 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | 31st Congress of the European-Society-for-Medical-Oncology -- SEP 29-OCT 03, 2006 -- Istanbul, TURKEY | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Soc Med Oncol | en_US |
dc.identifier.endpage | 77 | en_US |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.startpage | 77 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/26714 | |
dc.identifier.volume | 17 | en_US |
dc.identifier.wos | WOS:000248078900181 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Oxford Univ Press | en_US |
dc.relation.ispartof | Annals Of Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Trastuzumab beyond progression in metastatic breast cancer | en_US |
dc.type | Conference Object | en_US |